Local 12: Trial looks at treating pneumonia associated with COVID-19
Study examines anti-viral medication that could help reduce common complication of the coronavirus
A breakthrough trial is looking at a new anti-viral medication that could help reduce one of the most common complications of the COVID-19 coronavirus: pneumonia.
This new trial is one of a handful across the country looking at an antiviral therapy intended to stop the spread of this virus.
A team at the University of Cincinnati is conducting this research. Brett Kissela, MD, senior associate dean of clinical research at the UC College of Medicine and UC Health physician, is featured.
Read more about UC-led clinical trials.
Featured photo/Colleen Kelley/UC Creative + Brand
Related Stories
WLWT: Tips to fight off bad allergy symptoms
April 18, 2024
The University of Cincinnati's Ahmad Sedaghat spoke with WLWT about how Cincinnati's geography tends to make allergy symptoms worse and tips to fight off those symptoms.
Medscape: Skin adverse events rare after immunotherapy to treat...
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.
UC researchers develop new CPAP device
April 17, 2024
Researchers at the University of Cincinnati are developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.